Suppression of Coronary Atherosclerosis by Helix B Surface Peptide, a Nonerythropoietic, Tissue-Protective Compound Derived from Erythropoietin

• Главные авторы: Hiroto Ueba (Автор), Masashi Shiomi (Автор), Michael Brines (Автор), Michael Yamin (Автор), Tsutomu Kobayashi (Автор), Junya Ako (Автор), Shin-ichi Momomura (Автор), Anthony Cerami (Автор), Masanobu Kawakami (Автор)
• Формат: ‌
• Опубликовано: BMC, 2013-05-01T00:00:00Z.
• Предметы: article
• Online-ссылка: Connect to this object online.

Abstract Erythropoietin (EPO), a type I cytokine originally identified for its critical role in hematopoiesis, has been shown to have non-hematopoietic, tissue-protective effects, including suppression of atherosclerosis. However, prothrombotic effects of EPO hinder its potential clinical use in non...